| A multidisciplinary approach to pancreas cancer in 2016: a review EL Fogel, S Shahda, K Sandrasegaran, J DeWitt, JJ Easler, DM Agarwal, ... Official journal of the American College of Gastroenterology| ACG 112 (4 …, 2017 | 154 | 2017 |
| Three cachexia phenotypes and the impact of fat‐only loss on survival in FOLFIRINOX therapy for pancreatic cancer JK Kays, S Shahda, M Stanley, TM Bell, BH O'Neill, MD Kohli, ME Couch, ... Journal of cachexia, sarcopenia and muscle 9 (4), 673-684, 2018 | 135 | 2018 |
| APE1/Ref-1 regulates STAT3 transcriptional activity and APE1/Ref-1–STAT3 dual-targeting effectively inhibits pancreatic cancer cell survival AA Cardoso, Y Jiang, M Luo, AM Reed, S Shahda, Y He, A Maitra, ... Public Library of Science 7 (10), e47462, 2012 | 128 | 2012 |
| Circulating tumor cell detection using a parallel flow micro-aperture chip system CL Chang, W Huang, SI Jalal, BD Chan, A Mahmood, S Shahda, ... Lab on a Chip 15 (7), 1677-1688, 2015 | 123 | 2015 |
| Family caregiving challenges in advanced colorectal cancer: patient and caregiver perspectives CE Mosher, RN Adams, PR Helft, BH O’Neil, S Shahda, NA Rattray, ... Supportive care in cancer 24, 2017-2024, 2016 | 120 | 2016 |
| Regulation of HIF1α under hypoxia by APE1/Ref-1 impacts CA9 expression: dual targeting in patient-derived 3D pancreatic cancer models DP Logsdon, M Grimard, M Luo, S Shahda, Y Jiang, Y Tong, Z Yu, ... Molecular cancer therapeutics 15 (11), 2722-2732, 2016 | 116 | 2016 |
| Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers M Radovich, PJ Kiel, SM Nance, EE Niland, ME Parsley, ME Ferguson, ... Oncotarget 7 (35), 56491, 2016 | 111 | 2016 |
| Positive changes among patients with advanced colorectal cancer and their family caregivers: a qualitative analysis CE Mosher, RN Adams, PR Helft, BH O’Neil, S Shahda, NA Rattray, ... Psychology & Health 32 (1), 94-109, 2017 | 103 | 2017 |
| Phase 1 study of EUS-guided photodynamic therapy for locally advanced pancreatic cancer JM DeWitt, K Sandrasegaran, B O'Neil, MG House, NJ Zyromski, ... Gastrointestinal endoscopy 89 (2), 390-398, 2019 | 98 | 2019 |
| A phase 1b dose escalation study of Wnt pathway inhibitor vantictumab in combination with nab-paclitaxel and gemcitabine in patients with previously untreated metastatic … SL Davis, DB Cardin, S Shahda, HJ Lenz, E Dotan, BH O’Neil, ... Investigational new drugs 38, 821-830, 2020 | 90 | 2020 |
| Germline and somatic DNA damage repair gene mutations and overall survival in metastatic pancreatic adenocarcinoma patients treated with FOLFIRINOX A Sehdev, O Gbolahan, BA Hancock, M Stanley, S Shahda, J Wan, ... Clinical Cancer Research 24 (24), 6204-6211, 2018 | 82 | 2018 |
| The human metapneumovirus: a case series and review of the literature S Shahda, WG Carlos, PJ Kiel, BA Khan, CA Hage Transplant Infectious Disease 13 (3), 324-328, 2011 | 80 | 2011 |
| A phase II study of pembrolizumab in combination with mFOLFOX6 for patients with advanced colorectal cancer. S Shahda, AM Noonan, TS Bekaii-Saab, BH O'Neil, A Sehdev, WL Shaib, ... Journal of Clinical Oncology 35 (15_suppl), 3541-3541, 2017 | 76 | 2017 |
| A systematic review of psychosocial interventions for colorectal cancer patients CE Mosher, JG Winger, BA Given, S Shahda, PR Helft Supportive care in cancer 25, 2349-2362, 2017 | 69 | 2017 |
| The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy X Zhong, M Pons, C Poirier, Y Jiang, J Liu, GE Sandusky, S Shahda, ... Journal of cachexia, sarcopenia and muscle 10 (5), 1083-1101, 2019 | 63 | 2019 |
| Sex specificity of pancreatic cancer cachexia phenotypes, mechanisms, and treatment in mice and humans: role of Activin X Zhong, A Narasimhan, LM Silverman, AR Young, S Shahda, S Liu, ... Journal of cachexia, sarcopenia and muscle 13 (4), 2146-2161, 2022 | 59 | 2022 |
| Phase Ib study of Wnt inhibitor ipafricept with gemcitabine and nab-paclitaxel in patients with previously untreated stage IV pancreatic cancer E Dotan, DB Cardin, HJ Lenz, W Messersmith, B O'Neil, SJ Cohen, ... Clinical cancer research 26 (20), 5348-5357, 2020 | 57 | 2020 |
| Examining the effect of peer helping in a coping skills intervention: a randomized controlled trial for advanced gastrointestinal cancer patients and their family caregivers CE Mosher, E Secinti, SA Johns, BH O’Neil, PR Helft, S Shahda, SI Jalal, ... Quality of Life Research 27, 515-528, 2018 | 57 | 2018 |
| Identification of potential serum protein biomarkers and pathways for pancreatic cancer cachexia using an aptamer-based discovery platform A Narasimhan, S Shahda, JK Kays, SM Perkins, L Cheng, KNH Schloss, ... Cancers 12 (12), 3787, 2020 | 42 | 2020 |
| Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: a retrospective study OB Gbolahan, Y Tong, A Sehdev, B O’Neil, S Shahda BMC cancer 19, 1-9, 2019 | 42 | 2019 |
